Short cylindrical glass bottle (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Short cylindrical glass bottle (b) stopped with a rubber stopper and sealed with a metal cap around vial neck and lip; a plastic cap is attached to the metal cap such that when the plastic cap is pulled off, the seal on the metal cap is broken; vial is in a cardboard box (a) with a paper leaflet (c)
Number Of Parts
3
Part Names
a - box - Size: Length 5.7 cm x Width 2.9 cm x Depth 2.9 cm
b - vial - Size: Length 4.4 cm x Diam. 2.2 cm
c - leaflet (unfolded) - Size: Length 17.6 cm x Width 10.1 cm
(a) Front: "5 ML. Bio. 1568 // FLUOGEN® // Standardized according to the U.S. Public // Health Service requirements for the // 1973-74 season. // Stock 4-1568-1-70 // PARKE-DAVIS"; bottom: "Preservative: 0.01% thimerosal (mercury deriv.) // Polysorbate 80, USP, added during manufacture. // U.S. Licence No. 1. Canadian Licence No. 1. // Store at temperature between 2° and 8° C. // (36° and 46° F.). // FREEZING DESTROYS POTENCY // Parke, Davis & Company // Detroit, Michigan 48232 U.S.A."; back: "5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // C Contains no less than 1000 CCA units per human dose (0.5 // ml.) in the recommended ratio of 700 CCA units of the A // influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // PARKE-DAVIS"; top: "USUAL ADULT DOSE – Two intramuscular injections // of 0.5 ml. each, given at least two months apart. See // package insert. // [dose repeated in French] // Prepared from formalin-stabilized, zonally-centrifuged // antigens, ether-extracted from virus propogated in the // extraembryonic fluid of the chick embryo. // U.S. Patent No. 3,105,012"; right side: "5 ML. Bio. 1568 // FLUOGEN // Parke, Davis & Co. // Exp. Date and Lot [printed] Feb. 1, 1975 // 903033B [stamped]"; (b) front: "C // 5 ML. Bio. 1568 // INFLUENZA VIRUS VACCINE, BIVALENT // (IMMUNIZING ANTIGEN, ETHER EXTRACTED) // FLUOGEN® // Contains no less than 1000 CCA units per human dose // (0.5 ml.) in the recommended ratio of 700 CCA units of the A influenza virus component representative of A/England/ // 42/72 (H3N2) and 300 CCA units of the B influenza virus // component representative of B/Massachusetts/1/71. // Parke, Davis & Co., Detroit, Mich. 48232 U.S.A."; back: "USUAL ADULT DOSE – Two // intramuscular injections of 0.5 // ml. each, given at least two months apart. See package // inssert. // Standardized according to the // U.S. Public Health Service // requirements for the 1973-74 // season. // U.S. Lic. No. 1. // Canadian Lic. No. 1. // Exp Date and Lot [printed] // Feb. 1, 1975 // 903033B [stamped]"; bottom: "W // 83 [embossed]"; top: "FLIP // OFF [embossed]"; (c) "C // FLUOGEN® // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // PARKE-DAVIS // DESCRIPTION // [text follows] // 121 877800 C-PO // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from DESCRIPTION] // INDICATIONS // [text follows] // 121 877800 2 C - PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // [text continues from INDICATIONS] // CONTRAINDICATIONS // [text follows] // PRECAUTIONS // [text follows] // ADVERSE REACTIONS // [text follows] // 121 877800 3 C-PD // FLUOGEN // (INFLUENZA VIRUS VACCINE, BIVALENT) // IMMUNIZING ANTIGEN, ETHER EXTRACTED // DOSAGE AND ADMINISTRATION // [text follows] // PACKAGE INFORMATION // [text follows] // REFERENCES // [text follows] // 121 877800 //Parke, Davis & Co. // Detroit, Mi 48232 USA C-PD // A // Issued Aprile 1973 [French translation appears alongside English text throughout]"
Permanent Location
Storage Room 0010
0010-A
Condition Remarks
Box somewhat dirty, dented; no apparent problems wtih vial or leaflet
Copy Type
Original
Research Facts
This is a vaccine against the influenza virus and is administered intramuscular with hypodermic syringe.